Panel discussion
Swissmedic
| Website: | https://www.swissmedic.ch/ |
| Date: | April 22, 2024 |
| Time: | 15:30-16:15 |
| Room: | Sydney |
Panel title
How regulators can best support innovation
Panel summary
Regulatory agencies play a pivotal role in supporting Biotech R&D SMEs in their preparation of clinical trials and effective delivery of innovative and reliable therapies to patients. Engaging early with Biotech R&Ds increases the chances of complying with regulatory requirements. Experiences and available tools are discussed.
Speaker information
Moderation
Monika Jones
Panelists
Dr. Philippe Girard, Vice Director, Head of Medicinal product licences and surveillance, SWISSMEDIC Swiss Agency for Therapeutic Products
Daniel Meirelles Fernandes Pereira, Director, Member of the Board of Directors, ANVISA Brazilian Health Regulatory Agency
Bettina Ernst, CEO, Bernina Bioinvest & Innosuisse Innovation Council
Ulf Grawunder, PhD, Managing Partner, Viopas Venture Consulting, Basel, Switzerland; CEO, T-CURX, Würzburg, Germany
Company profile
Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products.
